GW Pharmaceuticals: cannabis on Nasdaq

UK drugs company’s public offering of 1.7million American Depositary Shares on the NASDAQ Global Market – funds come when its flagship product, Savitex, garnered a FDA Fast Track designation and its Epidiolex cannabidiol formulation received orphan drug designation for infants and young children.